Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population

Hôpital Edouard Herriot

Status: Completed

Conditions: FRENCH STUDY

Treatments: Diagnostic Test: UPPER ENDOSCOPY

Study type: Observational

Funder types: Other

Identifiers

NCT04224896

SFED

Details and patient eligibility

About

Narrow-Band Imaging (NBI) is as sensitive as Lugol chromoendoscopy to detect oesophageal squamous cell carcinoma (SCC) and appears more specific than Lugol chromoendoscopy in expert centres but its specificity in current practice is not known. This study aimed to prove the superiority of NBI specificity over Lugol chromoendoscopy to detect oesophageal SCC and high-grade dysplasia (HGD) in current practice (including tertiary care centres, local hospitals and private clinics).

Enrollment: 335 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients had a history or current SCC

Exclusion criteria

• NONE

Trial design

335 participants in 2 patient groups

NBI PATIENT

Treatment:

Diagnostic Test: UPPER ENDOSCOPY

LUGOL PATIENT

Treatment:

Diagnostic Test: UPPER ENDOSCOPY